Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Thijs

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
The Journal of Dermatological Treatment|August 24, 2016
Predicting therapy response to mycophenolic acid using UGT1A9 genotyping: towards personalized medicine in atopic dermatitisJ L Thijs, B A M Van Der Geest, J Van Der Schaft, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2017
Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysisJudith L Thijs, Ian Strickland, Carla A F M Bruijnzeel-Koomen, et al.
Lancet (London, England)|November 5, 1998
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trialF Forette, M L Seux, J A Staessen, et al.
The British Journal of Dermatology|January 1, 2019
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitisD S Bakker, L F M Ariens, C van Luijk, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2018
Serum biomarker profiles suggest that atopic dermatitis is a systemic diseaseJudith L Thijs, Ian Strickland, Carla A F M Bruijnzeel-Koomen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2022
Ocular surface disease is common in moderate-to-severe atopic dermatitis patientsRoselie E Achten, Daphne S Bakker, Chantal M van Luijk, et al.
Allergy|April 18, 2020
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registryLotte S Spekhorst, Lieneke F M Ariëns, Jorien van der Schaft, et al.
Journal of Human Hypertension|May 1, 1997
Therapy in old patients with isolated systolic hypertension: fourth progress report on the Syst-Eur trialR Antikainen, J Tuomilehto, L Thijs, et al.
Lancet (London, England)|September 23, 1997
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsJ A Staessen, R Fagard, L Thijs, et al.
Archives of Internal Medicine|August 13, 1998
Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the ElderlyJ A Staessen, R Fagard, L Thijs, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
The Journal of Dermatological Treatment|August 24, 2016
Predicting therapy response to mycophenolic acid using UGT1A9 genotyping: towards personalized medicine in atopic dermatitisJ L Thijs, B A M Van Der Geest, J Van Der Schaft, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2017
Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysisJudith L Thijs, Ian Strickland, Carla A F M Bruijnzeel-Koomen, et al.
Lancet (London, England)|November 5, 1998
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trialF Forette, M L Seux, J A Staessen, et al.
The British Journal of Dermatology|January 1, 2019
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitisD S Bakker, L F M Ariens, C van Luijk, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2018
Serum biomarker profiles suggest that atopic dermatitis is a systemic diseaseJudith L Thijs, Ian Strickland, Carla A F M Bruijnzeel-Koomen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2022
Ocular surface disease is common in moderate-to-severe atopic dermatitis patientsRoselie E Achten, Daphne S Bakker, Chantal M van Luijk, et al.
Allergy|April 18, 2020
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registryLotte S Spekhorst, Lieneke F M Ariëns, Jorien van der Schaft, et al.
Journal of Human Hypertension|May 1, 1997
Therapy in old patients with isolated systolic hypertension: fourth progress report on the Syst-Eur trialR Antikainen, J Tuomilehto, L Thijs, et al.
Lancet (London, England)|September 23, 1997
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsJ A Staessen, R Fagard, L Thijs, et al.
Archives of Internal Medicine|August 13, 1998
Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the ElderlyJ A Staessen, R Fagard, L Thijs, et al.
Pageof 19